Cargando…
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of dementia, affecting millions of people worldwide. Unfortunately, none of the current treatments are effective at improving cognitive function in AD patients and, therefore, there is an urgent need for the development of new therapies that target th...
Autores principales: | Calvo-Rodriguez, Maria, Kharitonova, Elizabeth K., Bacskai, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699688/ https://www.ncbi.nlm.nih.gov/pubmed/33233678 http://dx.doi.org/10.3390/cells9112513 |
Ejemplares similares
-
High mitochondrial calcium levels precede neuronal death in vivo in Alzheimer's disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020) -
Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020) -
Intracellular Calcium Dysregulation: Implications for Alzheimer's Disease
por: Magi, Simona, et al.
Publicado: (2016) -
Dysregulation of Protein Phosphorylation/Dephosphorylation
in Alzheimer's Disease: A Therapeutic Target
por: Gong, Cheng-Xin, et al.
Publicado: (2006) -
Calcium Dysregulation in Alzheimer’s Disease: A Target for New Drug Development
por: Wang, Yong, et al.
Publicado: (2017)